SS
DAWN

Sunbelt Securities’s Day One Biopharmaceuticals DAWN Stock Holding History

Sunbelt Securities’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42K Hold
66
– – ﹤0.01% 2014
2025
Q4 		$615 Hold
66
– – ﹤0.01% 2188
2025
Q3 		$465 Buy
+66
New +$454 ﹤0.01% 2236

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Sunbelt Securities's DAWN Position: Q1 2026 in Review

Sunbelt Securities held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 66 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Sunbelt Securities first reported a position in DAWN in Q3 2025 and has held it in 3 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Sunbelt Securities held 66 shares of Day One Biopharmaceuticals worth $1.42K as of Q1 2026.
  • Sunbelt Securities left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2014 holding.
  • Sunbelt Securities first reported a position in Day One Biopharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.